Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

DSG-mPEG(2000) is a PEGylated derivative of 1,2-distearoyl-sn-glycerol (DSG; Item No. 15079).1 It has been used in combination with other lipids in the formation of lipid nanoparticles (LNPs). LNPs containing DSG-mPEG(2000) and encapsulating a toll-like receptor 7 (TLR7) and TLR8 agonist and a peptide antigen each conjugated to poly(L-glutamic acid) (PGA) increase the activation of dendritic cells, macrophages, and B cells in the draining lymph node and dendritic cells and B cells in the spleen in mice compared to the non-LNP-encapsulated PGA-conjugated TLR7/8 agonist and peptide antigen.
WARNING This product is not for human or veterinary use.
1. Lipid-